Active, Not Recruiting
PRGN-3006 Adoptive Cellular Therapy for CD33-Positive Relapsed or Refractory AML, MRD Positive AML or Higher Risk MDS
NCT03927261
- Conditions
- Acute Myeloid Leukemia, Bone Marrow Diseases, Hematologic Diseases, +7 more
- Locations
-
- H Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States
- Mayo Clinic Rochester, Minnesota, United States